1、慢性心衰心肌能量代谢与有氧运动慢性心衰心肌能量代谢与有氧运动Chronic heart failure myocardial energy metabolism and aerobic exercise大庆油田总医院大庆油田总医院 范志清范志清 主主 要要 内内 容容慢性心衰治疗理念的进步慢性心衰治疗理念的进步心肌重构是由一系列复杂的分子和细胞机制导致的心肌结构、功能和表型...
OsteoarthritisPainPsychological adjustmentAn abstract is unavailable. This article is available as a PDF only.doi:10.1016/j.joca.2010.03.002DrexlerHelmutOsteoarthritis CartilageOsteoarthritis & CartilageLang R. Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs? Am Heart...
The management of heart failure has changed significantly over the last decade. This review focuses on the pharmacologic management of systolic heart failure, and provides current recommendations for the practicing acute care provider. View Full Article (HTML) Enhanced Article (HTML) Get PDF (96K)...
Chronic Heart Failure: Pathophysiology, Risk Factors, and Mechanisms aims to provide an inclusive overview on Chronic Heart Failure (CHF). This book is focused on the epidemiology, classification, molecular mechanisms, pathophysiology, causes, identification and interactions of heart ...
Hemodynamic determinants of activity measured by accelerometer in patients with stable heart failure JACC Heart Fail, 9 (2021), pp. 824-835 View PDFView articleView in ScopusGoogle Scholar 18 S. Ji, Y. Guo, G. Li, N. Sang NO2 exposure contributes to cardiac hypertrophy in male mice throug...
Acute heart failure (AHF) emerges either de novo or from worsening of chronic heart failure (CHF). The aim of the present study was to evaluate the association between worsening of CHF and mortality in AHF patients. Out of 152 included AHF patients, 47 (30.9%) were de novo AHF patients ...
Monitoring clinical changes in patients with heart failure: a comparison of methods Am Heart J, 150 (2005), pp. 707-715 View PDFView articleView in ScopusGoogle Scholar 12 S.J. Keteyian, E.S. Leifer, N. Houston-Miller, et al. Relation between volume of exercise and clinical outcomes in...
Candesartan has a moderate impact in preventing admissions for CHF among patients who have heart failure and LVEF higher than 40%. Published online Sept 1, 2003 http://image.thelancet.com/extras/03art7419web.pdf 展开 关键词: Humans Cardiovascular Diseases Tetrazoles Benzimidazoles Stroke Volume ...
This clinical trial compares the efficacy of omecamtiv mecarbil vs placebo in improving peak exercise capacity in patients with chronic heart failure with
14、elated) anemia, hyperphosphatemia, hyperparathyroidism,sleep apnea, generalized inflammation,Risk Factors,3、Cardiovascular abnormalities,Heart Failure,myocardial ischemic disease left ventricular hypertrophy salt and water retention,“low-pressure” pulmonary edema,Chest x-ray: a “bat wing” distributi ...